Abstract:This study is to associate the aggressiveness of cholesteatoma using Middle Ear Risk Index score and using miRNA‐21 and IL‐6 gene expression. Background Cholesteatoma, a destructive middle ear condition, poses challenges due to its variable clinical presentation and propensity for recurrence. Understanding its molecular underpinnings could enhance prognostication and guide therapeutic interventions. This study investigates the association between cholesteatoma aggressiveness, as assessed by the Middle Ear Risk Index (MERI), and the expression of miRNA‐21 and IL‐6 genes. Methods A cross‐sectional observational study involving 30 patients with cholesteatoma undergoing tympanomastoid exploration was conducted. MERI scores were calculated preoperatively, and cholesteatoma tissue was analyzed for miRNA‐21 and IL‐6 gene expression using RT‐PCR. Statistical analysis was performed to correlate MERI scores with gene expression levels. Results The majority (80%) of patients exhibited severe MERI scores, correlating with extensive middle ear pathology and necessitating canal wall‐down (CWD) mastoidectomy. Higher miRNA‐21 and IL‐6 gene expression levels were observed in cholesteatoma tissues, indicating local aggressiveness and inflammatory activity. Significant moderate correlations were found between MERI scores and miRNA‐21 (Pearson correlation = 0.579, p = 0.001) and IL‐6 gene expression (Pearson correlation = 0.388, p = 0.034). Patients with severe MERI scores had elevated miRNA‐21 and IL‐6 levels, suggesting a more aggressive disease phenotype. Conclusion MERI scores demonstrated utility in predicting cholesteatoma aggressiveness, with higher scores correlating with elevated miRNA‐21 and IL‐6 expression. These findings suggest a potential role for MERI in guiding surgical decision‐making and prognostication. Future research on targeted therapies based on molecular mechanisms holds promise for improving cholesteatoma management. Level of Evidence 3 Laryngoscope, 2024

Expression of Vascular Endothelial Growth Factor and Its Clinical Significance in Middle Ear Cholesteatoma

Expression of Human Vascular Endothelial Growth Factor in Ampullary Carcinoma and Its Significance

Enhanced Mitophagy in Cholesteatoma Epithelial Cells.

Expressions of EGFR and Phosphotyrosine in Human Middle Ear Cholesteatoma

[Expression of Vascular Endothelial Growth Factor and Its Receptors in Laryngeal Carcinoma Cell and Its Significance].

A study of the protein tyrosine kinases pathway in human middle ear cholesteatoma

The role of EGFR/PI3K/Akt/cyclinD1 signaling pathway in acquired middle ear cholesteatoma.

The Expression and Significance of Heat Shock Protein 70 and Proliferating Cell Nuclear Antigen Protein in Human Middle Ear Cholesteatoma

Study on the Relationship Between the Proliferation and Apoptosis of Auditory Meatal Skin in Cholesteatoma

Expression of the tumor suppressor gene PTEN in human middle ear cholesteatoma and its clinical significance

Expression and Significance of Tumor Necrosis Factor-α and Matrix Metalloproteinase-9 in Human Middle Ear Cholesteatoma

Expression of MMP-14 and its role in bone destruction in middle ear cholesteatoma: A prospective observational study

Role of Autophagy in Acquired Cholesteatoma

The Expression and Clinical Significance of Vascular Endothelial Growth Factor-C in Gastric Cancer Tissues

Activation of the EGFR/Akt/NF-κB/cyclinD1 survival signaling pathway in human cholesteatoma epithelium

[Role of Epithelial Cell Proliferation and Apoptosis in Human Middle Ear Cholesteatoma].

[Advance Research on the Pathogenesis of Middle Ear Cholesteatoma].

Study on the Correlation Between Tympanic Membrance Epidermal Stem Cells and the Middle Ear Cholesteatoma

[Activation of Nuclear Factor-Kappab and Aberrant Gene Expression of Interleukin 6 in Middle Ear Cholesteatoma].

Prognostic Significance of Vascular Endothelial Growth Factor Expression and Microvessel Density in Carcinoma of Ampulla of Vater.

Unveiling the Aggressiveness of Cholesteatoma: Associating MERI with miRNA‐21 & IL‐6 Expression